Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 179,703 shares at $13.17 ($2.4M) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Seasonal sale ($2.4M) by President and COO — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.17 | 122,523 | $1.6M | 68.0% |
| 2 | $14.08 | 19,060 | $268K | 11.3% |
| 3 | $12.63 | 13,660 | $173K | 7.3% |
| 4 | $13.43 | 5,400 | $73K | 3.1% |
| 5 | $12.96 | 19,060 | $247K | 10.4% |
| Total | $13.21 avg | 179,703 |
| $2.4M |
| 100% |
| Filing → |
| ADPT | SELL | 2026-10-05 | $1.0M | — | Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |